ENCell Co., Ltd. (KOSDAQ:456070)
South Korea · Delayed Price · Currency is KRW 5,900.00
-70.00 (-1.17%)
Sep 22, 2026, 3:30 PM KST
ENCell Market Cap
ENCell has a market cap or net worth of 65.07 billion as of September 22, 2026. Its market cap has decreased by -50.09% in one year.
Market Cap
65.07B
Enterprise Value
46.81B
Revenue
4.16B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,900.00
ChartMarket Cap Chart
Since August 23, 2024, ENCell's market cap has decreased from 160.82B to 65.07B, a decrease of -59.54%. That is a compound annual growth rate of -35.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 65.07B | -67.22% |
| Dec 30, 2025 | 198.50B | 7.25% |
| Dec 30, 2024 | 185.09B | 15.09% |
| Aug 23, 2024 | 160.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anterogen.Co.,Ltd. | 151.49B |
| Helixmith | 140.44B |
| Genexine | 131.89B |
| Vaxcell-Bio Therapeutics | 100.24B |
| MedPacto | 93.23B |
| iNtRON Biotechnology | 87.42B |
| Prestige BioPharma | 71.88B |
| Amicogen | 63.41B |